BaranDSumerMDFACS

Otolaryngology (ENT) • Dallas, TX

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery

TC Lupton Professorship Professor, Otolaryngology , Head & Neck Surgery, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Sumer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sumer's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 469-604-9000

Fax+1 469-604-9001

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 2001 - 2006
Washington University/B-JH/SLCH ConsortiumInternship, Surgery, 2001 - 2002
Case Western Reserve University School of MedicineClass of 2001

Certifications & Licensure

TX State Medical License 2008 - 2026
MO State Medical License 2006 - 2015
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (FACS) American College of Surgeons
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck Cancer Start of enrollment: 2009 Jul 08
Terminated
Phase 1
Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
Terminated
Phase 3
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer Start of enrollment: 2013 Nov 18
Completed
Phase 1
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) Start of enrollment: 2024 Apr 17
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial.
David J Sher, Vladimir Avkshtol, Dominic Moon, Dat Vo, Ted Mau
International Journal of Radiation Oncology, Biology, Physics. 2024-07-20
1 citations
Stepwise Ultra-pH-Sensitive Micelles Overcome a pBarrier for Systemic Lymph Node Delivery.
Zachary T Bennett, Gang Huang, Michael T Dellinger, Baran D Sumer, Jinming Gao
ACS Nano. 2024-07-02
6 citations
Severely polarized extracellular acidity around tumour cells.
Qiang Feng, Zachary Bennett, Anthony Grichuk, Raymundo Pantoja, Tongyi Huang
Nature Biomedical Engineering. 2024-06-01

Press Mentions

Texas Researchers Find ‘Acid Walls’ That Shield Cancer Tumors from Body’s Immune System ResponseSeptember 20th, 2024
Building a Brighter Way for Capturing Cancer During SurgerySeptember 30th, 2019
North Texas Invention to Help Doctors Fight CancerDecember 27th, 2016
Join now to see all

Professional Memberships

Other Languages

Spanish, Turkish

External Links

For Referralshttp://www.utsouthwestern.edu/patientcare/doctor/findphysician/profile/0,0,94227_Dr_Baran_Sumer_MD,00.html